215
Participants
Start Date
March 8, 2024
Primary Completion Date
June 3, 2024
Study Completion Date
June 28, 2024
DWJ1609
Drug of test group
DWC202304
Drug of control group
Kangbuk Samsung Hospital, Seoul, Korea
Lead Sponsor
Daewoong Pharmaceutical Co. LTD.
INDUSTRY